SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
-7.05%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$265M
AUM Growth
+$265M
(-7.6%)
Cap. Flow
+$3.81M
Cap. Flow
% of AUM
1.44%
Top 10 Holdings %
Top 10 Hldgs %
63.41%
Holding
63
New
13
Increased
11
Reduced
8
Closed
15
Top Buys
| 1 |
Teleflex
TFX
|
$16.2M |
| 2 |
Smith & Nephew
SNN
|
$14.4M |
| 3 |
Corbus Pharmaceuticals
CRBP
|
$10.2M |
| 4 |
VXRT
Vaxart
VXRT
|
$9.85M |
| 5 |
Abbott
ABT
|
$9.3M |
Top Sells
| 1 |
Globus Medical
GMED
|
$21.1M |
| 2 |
Cigna
CI
|
$16.3M |
| 3 |
Madrigal Pharmaceuticals
MDGL
|
$13.6M |
| 4 |
Medtronic
MDT
|
$9.15M |
| 5 |
Embecta
EMBC
|
$7.77M |
Sector Composition
| 1 | Healthcare | 96.64% |
| 2 | Consumer Staples | 3.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Pacira BioSciences
PCRX
$1.22B
| – | – |
0
| – | – |
|
52
Ocular Therapeutix
OCUL
$2.25B
| – | – |
-383,026
| Closed | -$3.49M |
|
|
53
Medtronic
MDT
$118B
| – | – |
-105,000
| Closed | -$9.15M |
|
|
54
Madrigal Pharmaceuticals
MDGL
$9.7B
| – | – |
-51,000
| Closed | -$13.6M |
|
55
Ironwood Pharmaceuticals
IRWD
$201M
| – | – |
-149,400
| Closed | -$1.3M |
|
56
Insmed
INSM
$30.3B
| – | – |
0
| – | – |
|
57
IDEAYA Biosciences
IDYA
$2.26B
| – | – |
-33,007
| Closed | -$1.45M |
|
58
Integra LifeSciences
IART
$1.18B
| – | – |
-137,000
| Closed | -$4.86M |
|
59
Humacyte
HUMA
$231M
| – | – |
-2,000,000
| Closed | -$6.22M |
|
60
Healthcare Services Group
HCSG
$1.14B
| – | – |
-421,317
| Closed | -$5.26M |
|
|
61
Globus Medical
GMED
$7.94B
| – | – |
-393,420
| Closed | -$21.1M |
|
|
62
Embecta
EMBC
$837M
| – | – |
-585,418
| Closed | -$7.77M |
|
63
CytomX Therapeutics
CTMX
$350M
| – | – |
-1,598,590
| Closed | -$3.48M |
|